Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

• Annalisa Ruggeri,
• Liesbeth C. de Wreede,
• Carlheinz R. Müller,
• Pietro Crivello,
• Edouard F. Bonneville,
• Effie W. Petersdorf,
• Gerard Socié,
• Valérie Dubois,
• Riitta Niittyvuopio,
• Juha Peräsaari,
• Ibrahim Yakoub-Agha,
• Jan J. Cornelissen,
• Lotte Wieten,
• Tobias Gedde-Dahl,
• Edouard Forcade,
• Charles R. Crawley,
• Steven G.E. Marsh,
• Virginie Gandemer,
• Eleni Tholouli,
• Claude-Eric Bulabois,
• Anne Huynh,
• Goda Choi,
• Eric Deconinck,
• Maija Itäla-Remes,
• Stig Lenhoff,
• Mats Bengtsson,
• Jan-Erik Johansson,
• Gwendolyn van Gorkom,
• Jorinde D. Hoogenboom,
• Luca Vago,
• Vanderson Rocha,
• Chiara Bonini,
• Christian Chabannon,
• Katharina Fleischhauer

Affiliations

Annalisa Ruggeri

San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden

Liesbeth C. de Wreede

Leiden University Medical Center, Leiden

Carlheinz R. Müller

Zentrales Knochenmarkspender-Register Deutschland, Ulm

Pietro Crivello

Institute for Experimental Cellular Therapy, University Hospital Essen, Essen

Edouard F. Bonneville

Leiden University Medical Center, Leiden

Effie W. Petersdorf

Fred Hutchinson Cancer Research Center, Seattle

Gerard Socié

Hôpital St. Louis, Paris

Valérie Dubois

Histocompatibility Laboratory, EFS Lyon

Riitta Niittyvuopio

HUCH Comprehensive Cancer Center, Helsinki

Juha Peräsaari

Clinical Laboratory Services, Histocompatibility Testing, Finnish Red Cross Blood Service, Helsinki

Ibrahim Yakoub-Agha

CHU de Lille, Lille

Jan J. Cornelissen

Erasmus MC Cancer Institute, Rotterdam

Lotte Wieten

Transplantation Immunology, Maastricht University Medical Center, Maastricht

Tobias Gedde-Dahl

Oslo University Hospital, Rikshospitalet, Oslo

Edouard Forcade

CHU Bordeaux, Pessac

Charles R. Crawley

Addenbrookes Hospital, Cambridge

Steven G.E. Marsh

Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London,

Virginie Gandemer

Centre Hospitalier Universitaire de Rennes, Rennes

Eleni Tholouli

Manchester Royal Infirmary, Manchester

Claude-Eric Bulabois

CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble

Anne Huynh

CHU - Institut Universitaire du Cancer Toulouse, Toulouse

Goda Choi

University Medical Center Groningen (UMCG), Groningen

Eric Deconinck

Hopital Jean Minjoz, Besancon

Maija Itäla-Remes

Turku University Hospital, Turku

Stig Lenhoff

Skanes University Hospital, Lund

Mats Bengtsson

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala

Jan-Erik Johansson

Sahlgrenska University Hospital, Goeteborg

Gwendolyn van Gorkom

University Hospital Maastricht, Maastricht

Jorinde D. Hoogenboom

EBMT Leiden Study Unit, Leiden

Luca Vago

San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden

Vanderson Rocha

Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31) of the Service of Hematology and Cell Therapy, Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, SP

Chiara Bonini

San Raffaele Scientific Institute, Hematology and Bone marrow Transplantation Unit, Milan, Italy; Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden

Christian Chabannon

Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institut Paoli-Calmettes, Centre de Lutte Contre le Cancer; Centre d'Investigations Cliniques en Biothérapie, Université d'Aix-Marseille, Inserm CBT 1409, Marseille

Katharina Fleischhauer

Cellular Therapy and Immunobiology Working Party of the EBMT, Leiden, The Netherlands; Institute for Experimental Cellular Therapy, University Hospital Essen, Essen